Microvascular thrombosis and multiple organ dysfunction syndrome

Critical Care Medicine

Volumn 38, Issue SUPPL. 2, 2010, Pages

  Gando, Satoshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coagulation; Cytokine; Disseminated intravascular coagulation; Endothelium; Inflammation; Multiple organ dysfunction syndrome; Neutrophil; Protease activated receptor; Systemic inflammatory response syndrome; Thrombosis

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEINASE ACTIVATED RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM; HUMAN; MICROVASCULAR THROMBOSIS; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 74949123200     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181c9e31d     Document Type: Review

References (83)

1. Halevy DH, Radhakrishnan J, MarKowitz G, et al: Thrombotic microangiopathies. Crit Care Clin 2002; 18:309-320
2. Levi M, ten Cate H: Disseminated intravas-cular coagulation. N Engl J Med 1999; 341: 586-592
3. Merrill JT, Asherson RA: Catastrophic an-tiphospholipid syndrome. Nat Clin Pract Rheumatol 2006; 2:81-89
4. Mihu D, Costin M, Mihu CM, et al: HELLP syndrome-A multisystemic disorder. J Gas-trointest Liver Dis 2007; 16:419-424
5. Allford SL, Hunt BJ, Rose P, et al: Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003; 120:556-573
6. Asherson RA, Espinosa G, Cervera R, et al: Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: Clinical and haematological characteristics. Ann Rheum Dis 2005; 64:943-946 (Pubitemid 40733924)
7. Taylor FB Jr, Toh CH, Hoots WK, et al: Toward definition, clinical and laboratory criteria, and scoring system for disseminated in-travascular coagulation. Thromb Haemost 2001; 86:1327-1330
8. Ivanyi B, Thoenes W: Microvascular injury and repair in acute human bacterial pyelonephritis. Virch Arch Pathol Anat Histopathol 1987; 411:257-265
9. Asakura H, Suga Y, Yoshida T, et al: Patho-physiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccha-ride-induced DIC models in rats. Blood Co-agul Fibrinolysis 2003; 14:221-228
10. Barbui T, Falanga A: Disseminated intravas-cular coagulation in acute leukemia. Semin Thromb Haemost 2001; 27:593-604
11. Yoshikawa T, Tanaka KR, Guze LB: Infection and disseminated intravascular coagulation. Medicine 1971; 50:237-258
12. Kojima M, Shimamura K, Mori N, et al: A histopathological study on microthrombi in autopsy cases of DIC. Bibl Haematol 1983; 49:95-106
13. Shimamura K, Oka K, Nakazawa M, et al: Distribution patterns of microthrombi in disseminated intravascular coagulation. Arch Pathol Lab Med 1983; 107:543-547
14. Robboy SJ, Mihm MC, Colman RW, et al: Skin in disseminated intravascular coagulation: Prospective analysis of thirty-six cases. Br J Dermatol 1973; 88:221-229
15. Schwartzman RJ, Hill JB: Neurologic complications of disseminated intravascular coagulation. Neurology 1982; 32:791-797
16. Kojima M, Shimamura K, Kanari T: Endo-toxin and DIC. Aoki N (Ed). In: DIC and Related Disorders. Tokyo. Ishiyaku-shuppan, 1980, pp 66-72
17. Taylor FB Jr, Chang AK, Mather T, et al: DEGR-factor Xa blocks disseminated intra-vascular coagulation initiated by E. Coli without preventing shock or organ damage. Blood 1991; 78:364-371
18. Taylor FB Jr, Chang AC, Peer G, et al: Active site inhibited factor VIIa (DEGR VIIa) attenuate the coagulant and interleukin-6 and-8 but not tumor necrosis factor, responses of the baboon to LD 100 Escherichia coli. Blood 1998; 91:1609-1615
19. Taylor FB, Jr., Chang AC, Ruf W, et al: Lethal septic shock is prevented by blocking tissue factor. Circ Shock 1991; 33:127-134
20. Creasey AA, Chang AC, Fiegan L, et al: Tissue factor pathway inhibitor (TFPI) reduces mortality from Escherichia coli septic shock. J Clin Invest 1993; 91:2850-2860
21. Levi M, van der Poll T, ten Cate H, et al: The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxemia. Eur J Clin Invest 1997; 27:3-9
22. Esmon CT: Possible involvement of cyto-kines in diffuse intravascular coagulation and thrombosis. Baillieres Clin Haematol 1999; 12:343-359
23. McGill SN, Ahmed NA, Christou CA, et al: Endothelial cells: Role in infection and inflammation. World J Surg 1998; 22:171-178
24. McEver RP: GMP-140: A receptor for neutro-phils and monocytes on activated platelets and endothelium. J Cell Biochem 1991; 45: 156-161
25. Bevilacqua MP: Endothelial-leucocyte adhesion molecules. Ann Rev Immunol 1993; 11: 767-804
26. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-376
27. Cines DB, Pollak ES, Buck CA, et al: Endo-thelial cells in physiology and in the patho-physiology of vascular disorders. Blood 1998; 91:3527-3561
28. Furie B, Furie BC: The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: Role of P-selectin and the P-selectin ligand, PSGL-1 Thromb Haemost 1995; 74:224-227
29. Tiruppathi C, Naqvi T, Sandoval R, et al: Synergistic effects of tumor necrosis factor-alpha and thrombin in increasing endothelial permeability. Am J Physiol Lung Cell Mol Physiol 2001; 281:L958-L968
30. Parent C, Eichacker PQ: Neutrophil and en-dothelial cell interactions in sepsis. The role of adhesion molecules. Infect Dis Clin North Am 1999; 13:427-447
31. Esmon CT: Inflammation and thrombosis. J Thromb Haemost 2003; 1:1343-1348
32. Coughlin SR: Thrombin signaling and pro-tease-activated receptors. Nature 2000; 407: 258-264
33. Camerer E, Huang W, Coughlin SR: Tissue factor-and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 2000; 97:5255-5260
34. Riwald M, Ruf W: Orchestration of coagulation protease signaling by tissue factor. Trend Cardiovasc Med 2002; 12:149-154
35. Riwald M, Ruf W: Role of coagulation protease cascades in sepsis. Crit Care 2003; 7:123-129
36. Pawlinski R, Mackman N: Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med 2004; 32(Suppl.):S293-S297
37. Camerer E, Cornelissen I, Kataoka H, et al: Roles of protease-activated receptors in a mouse model of endotoxemia. Blood 2006; 107:3912-3921
38. Pawlinski R, Pedersen B, Schabbauer G, et al: Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004; 103:1342-1347
39. Slofstra SH, Bijlsma MF, Groot AP, et al: Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation. Blood 2007; 110:3176-3182
40. Jesmin S, Gando S, Zaedi S, et al: Chronogi-cal expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis. Thromb Haemost 2006; 96:830-838
41. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-251
42. Ito T, Kawahara K, Nakamura T, et al: High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost 2007; 5:109-116
43. Tsai HM: ADAMTS13 and microvascular thrombosis. Expert Rev Cardiovasc Ther 2006; 4:813-825
44. Chauhan AK, Motto DG, Lamb CB, et al: Systemic antithrombotic effects of AD-AMTS13. J Exp Med 2006; 203:767-776
45. Martin K, Borgeri D, Lerolle N, et al: Decreased ADAMTS13 is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 2007; 35:2375-2382
46. Bockmeyer CL, Claus RA, Budde U, et al: Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor. Haematologica 2008; 93: 137-140
47. Ono T, Mimuro J, Madoiwa S, et al: Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-associated disseminated in-travascular coagulation: Its correlation with development of renal failure. Blood 2006; 107:528-534
48. Nguyen TC, Han YY, Kiss JE, et al: Intensive plasma exchange increases disintegrin and metalloprotease with thrombospondin mo-tifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 2008; 36:2878-2887
49. Papadopoulos MC, Davies DC, Moss RF, et al: Pathophysiology of septic encephalopathy: A review. Crit Care Med 2000; 28:3019-3024
50. Jackson AC, Gilbert JJ, Young GB, et al: The encephalopathy of sepsis. Can J Neurol Sci 1985; 12:303-307
51. Finelli PF, Uphoff DF: Magnetic resonance imaging abnormalities with septic encepha-lopathy. J Neurol Neurosurg Psych 2004; 75: 1189-1191
52. Sharshar T, Annane D, de la Grandmaison GL, et al: The neuropathology of septic shock. Brain Pathol 2004; 14:21-33
53. Erlich J, Fearns C, Mathison J, et al: Lipo-polysaccharide induction of tissue factor expression in rabbits. Infect Immun 1999; 67: 2540-2546
54. Jesmin S, Gando S, Zaedi S, et al: Expression of 4 protease-activated receptors is associated with increased levels of TNF-alpha, tissue factor, and fibrin in the frontal cortex of endotoxemic rats. Thromb Res 2009; 124: 498-501
55. Welty-Wolf KE, Carraway MS, Ortel TL, et al: Coagulation and inflammation in acute lung injury. Thromb Haemost 2002; 88:17-25
56. Bachofen M, Weibel ER: Alteration of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 1977; 116:589-615
57. Kaplan JE, Malik AB: Thrombin-induced in-travascular coagulation: Role in vascular injury. Semin Thromb Haemost 1987; 13: 398-415
58. Johnson A, Tahamont MV, Malik AB: Throm-bin-induced lung vascular injury: Role of fi-brinogen and fibrinolysis. Am Rev Respir Dis 1983; 128:38-44
59. Tahamont MV, Malik AB: Granulocytes mediates the increase in pulmonary permeability after thrombin embolism. J Appl Physiol 1983; 54:1489-1495
60. Johnson A, Garcia-Szabo RR, Kaplan JE, et al: Fibrin degradation products increase lung transvascular fluid filtration after thrombin-induced pulmonary microembolization. Thromb Res 1985; 37:543-554
61. Gando S, Kameue T, Matsuda N, et al: Systemic inflammation and disseminated intra-vascular coagulation in early stage of ALI and ARDS: Role of neutrophil and endothelial activation. Inflammation 2004; 28:237-244
62. Jesmin S, Gando S, Matsuda N, et al: Temporal changes in pulmonary expression of key pro-coagulant molecules in rabbits with endotoxin-induced acute lung injury: Elevated expression levels of protease-activated receptors. Thromb Haemost 2004; 92:966-979
63. Dhainaut JF, Marin N, Mignon A, et al: Hepatic response to sepsis: Interaction between coagulation and inflammatory processes. Crit Care Med 2001; 29(Suppl.):S42-S47
64. Shibayama Y: Sinusoidal circulatory disturbance by microthrombosis as a cause of en-dotoxin-induced hepatic injury. J Pathol 1987; 151:315-321
65. Hewett JA, Jean PA, Kunkel SL, et al: Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury. Am J Physiol Gastrointest Liver Physiol 1993; 265:G1011-G1015
66. Luster MI, Germolec DR, Yoshida T, et al: Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 1994; 19:480-488
67. Fearns C, Loskutoff DJ: Induction of plas-minogen activator inhibitor-1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-alpha. Am J Pathol 1997; 150:579-590
68. Mochida S, Arai M Ohno A, et al: Deranged blood coagulation equilibrium as a factor of massive necrosis following endotoxin administration in partially hepatectomized rats. Hepatology 1999; 29:1532-1540
69. Mochida S, Ogata I, Hirata K, et al: Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 1990; 99:771-777
70. Hertig A, Rondeau E: Role of coagulation/ fibrinolysis system in fibrin-associated glo-merular injury. J Am Soc Nephrol 2004; 15: 844-853
71. Holdsworth SR, Tipping PG: Macrophage-induced glomerular fibrin deposition in ex-perimental glomerulonephritis in the rabbit. J Clin Invest 1985; 76:1367-1374
72. Tipping PG, Erlich JH, Apostolopoulos J, et al: Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol 1995; 147:1736-1748
73. Wiggins RC, Njoku N, Sedor JR: Tissue factor production by cultured rat mesangial cells. Stimulation by TNF-alpha and lipopolysac-charide. Kidney Int 1990; 37:1281-1285
74. Welty-Wolf KE, Carraway MS, Miller DL, et al: Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med 2001; 164:1988-1996
75. Jesmin S, Gando S, Zaedi S, et al: Protease-activated receptor 2 (PAR2) blocking peptide counteracts endotoxin-induced inflammation and coagulation and ameliorates renal fibrin deposition in a rat model of acute renal failure. Shock 2009; 32:626-632
76. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 1996; 24:163-172
77. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study. JAMA 1995; 273:117-123
78. Gando S, Kameue T, Nanzaki S, et al: Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996; 75:224-228
79. Gando S, Kameue T, Matsuda N, et al: Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb Haemost 2002; 88: 943-949
80. Gando S, Kameue T, Matsuda N, et al: Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation. Thromb Res 2005; 116:91-100
81. Fourrier F, Chopin C, Goudemand J, et al: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101: 816-823
82. Dhainaut JF, Shorr AF, Macias WL, et al: Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure. Crit Care Med 2005; 33:341-348
83. Ogura H, Gando S, Iba T, et al: SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocy-topenia. Shock 2007; 28:411-417